Zimmer Biomet price target lowered to $113 from $118 at Truist
Truist analyst Richard Newitter lowered the firm’s price target on Zimmer Biomet (ZBH) to $113 from $118 and keeps a Hold rating on the shares.
Zimmer Biomet: Adding To The Growth Profile
Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...
Zimmer Biomet price target lowered to $119 from $126 at Raymond James
Raymond James lowered the firm’s price target on Zimmer Biomet (ZBH) to $119 from $126 and keeps an Outperform rating on the shares. Zimmer ...
Why Is Zimmer Biomet Stock Trading Lower On Thursday?
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the ...
Morningstar4d
Zimmer Biomet Earnings: Steady Fourth-Quarter Results
Coming up: We think there are a couple of opportunities in 2025 for Zimmer Biomet to raise its profile in large joints as it introduces some new products. The firm should move into full ...
Benzinga.com13d
Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details
“Paragon 28’s broad and innovative foot and ankle portfolio, robust product pipeline and dedicated and highly trained sales force, combined with Zimmer Biomet’s global reach and ...
Morningstar13d
Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28
"Paragon 28's broad and innovative foot and ankle portfolio, robust product pipeline and dedicated and highly trained sales force, combined with Zimmer Biomet's global reach and capabilities ...